Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

25 November 2022

6 ways the pharmaceutical industry can reduce its climate impact

In an op-ed for the World Economic Forum on climate change, our CEO, Jay Iyer, highlights the link between health and climate, and the role that pharmaceutical companies can play.

Direct links

Read the article

Setting out six simple steps, Jay articulates the special position that the pharmaceutical industry occupies and how it can take action:

"...industry has a unique responsibility to act, not only to reduce its greenhouse gas emissions through net-zero strategies but to combat the adverse health consequences of the climate emergency. To do this effectively, companies need to get ahead of the curve, both in terms of medicines they are developing and the access they are providing to those people on the frontline of the climate crisis, who overwhelmingly live in resource-poor settings."

Read the article on the World Economic Forum website.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved